MedTrace Logo

Evaluation of a Finger Prick Collection Method for Measuring Alzheimer's Disease Blood Biomarkers

NCT07187921 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 49

Last updated 2025-12-09

No results posted yet for this study

Summary

This is an observational study that will collect blood from a finger prick (Capitainer SEP10 single channel device) and assess the accuracy of pTau-217 testing in comparison to previously collected venous blood samples from the same individuals.

Conditions

  • Alzheimer Disease

Sponsors & Collaborators

  • National Institute on Aging (NIA)

    collaborator NIH

  • Banner Health

    lead OTHER

Principal Investigators

  • Jessica B Langbaum, PhD · Banner Alzheimer's Institute

Eligibility

Min Age
50 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-09-29
Primary Completion
2025-11-12
Completion
2025-11-12

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07187921 on ClinicalTrials.gov